1. Department of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy; 2. Department of Cardiology, Vivantes Klinikum im Friedrichshain and Vivantes Klinikum Am Urban, Berlin, Germany; 3. Rostock University Medical Center, Rostock, Germa
Even if the majority of patients treated with MitraClip will benefit from the treatment, it is easy to understand that the more advanced the cardiac disease the less beneficial the treatment will be. Data from many registries